Clinical experience with transcatheter tricuspid valve replacement

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: J. Hausleiter, R. Puri

Speakers: I. Mattig, J. Curio, D. Mehrkens, T. Modine, R. Puri, Q. Arshad

Summary

This session shares clinical experience with transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. It includes outcomes after prior repair, analysis of stent frame geometry as a predictor of leaflet abnormalities, and assessments of functional and quality-of-life improvements with systems such as Evoque and MonarQ. Additionally, it reviews trial outcomes including the TRINITY and TRICAV studies, highlighting novel caval reflux strategies and early results of emerging TTVR technologies.

Presentations available when logged in:

Transcatheter tricuspid valve replacement for severe tricuspid regurgitation after prior repair
TTVR stent frame geometry: Eccentric device expansion as predictor of HALT and RLM
Functional and quality-of-life outcomes after TTVR with the Evoque system
12-month TRINITY trial outcomes using the LuX-Valve plus TTVR system
Early outcomes of TRICAV: a novel caval reflux strategy for severe tricuspid regurgitation

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Clinical experience with transcatheter tricuspid valve replacement

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free